Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective
沙特阿拉伯皮下注射英夫利昔单抗(CT-P13 SC)治疗炎症性肠病的预算影响分析:从支付方角度的分析
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0312603
Alkhatib, Nimer S; Almutairi, Abdulaali R; Almadi, Majid; Halloush, Shiraz; Al-Ruthia, Yazed Sulaiman H; Rashdan, Omar; Al-Shatnawi, Samah; Azzam, Nahla A; Mosli, Mahmoud H; Badawoud, Amal M; Al Yami, Majed S; Alhossan, Abdulaziz; AlHarbi, Ibtisam